866 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Company News For May 29, 2019 http://www.zacks.com/stock/news/421315/company-news-for-may-29-2019?cid=CS-ZC--421315 May 29, 2019 - Companies in the news are: UBER, TEVA, AMD and ASGN
Why Teva Pharmaceutical Industries, Seadrill, and Nutanix Slumped Today https://www.fool.com/investing/2019/05/28/why-teva-pharmaceutical-industries-seadrill-and-nu.aspx?source=iedfolrf0000001 May 28, 2019 - Tough industry conditions took their toll on some stocks.
Here's Why Teva Pharmaceutical Is Sinking Today https://www.fool.com/investing/2019/05/28/heres-why-teva-pharmaceuticals-is-sinking-today.aspx?source=iedfolrf0000001 May 28, 2019 - A larger-than-expected legal settlement might be a harbinger of things to come.
Teva launches generic Ranexa in U.S. https://seekingalpha.com/news/3467223-teva-launches-generic-ranexa-u-s?source=feed_news_all May 28, 2019 - Teva Pharmaceutical Industries (TEVA -12.9%) commences the U.S. commercial launch of its generic version of Gilead Sciences' (GILD -3.2%) angina med Ranexa (ranolazine) Extended-Release Tablets, 500 m
Prosecutors say J&J ran 'deceitful, multibillion-dollar brainwashing campaign' in key opioid trial https://www.cnbc.com/2019/05/28/prosecutors-say-jj-ran-deceitful-brainwashing-campaign-in-opioid-trial.html May 28, 2019 - Oklahoma state prosecutors blasted J&J in the first day of a landmark opioid trial Tuesday, saying it ran a "deceitful, multibillion-dollar brainwashing campaign" that led to more than 46,000 deaths in the state over a decade.
Biocept and OncoSec Medical among healthcare gainers; Teva Pharmaceutical and Zynerba Pharmaceuticals among losers https://seekingalpha.com/news/3467171-biocept-oncosec-medical-among-healthcare-gainers-teva-pharmaceutical-zynerba-pharmaceuticals?source=feed_news_all May 28, 2019 - Gainers: Soliton (NASDAQ:SOLY) +80%. Biocept (NASDAQ:BIOC) +25%. Armata Pharmaceuticals (NYSEMKT:ARMP) +16%. OncoSec Medical (NASDAQ:ONCS) +15%. MYnd Analytics (NASDAQ:MYND) +10%.Losers: Kezar Life Sc
Teva settles opioid case with Oklahoma for $85M https://seekingalpha.com/news/3467024-teva-settles-opioid-case-oklahoma-85m?source=feed_news_all May 28, 2019 - Without admitting any wrongdoing, Teva Pharmaceutical Industries (NYSE:TEVA) has agreed to settle claims by the U.S. state of Oklahoma over its role in the opioid crisis there via a one-time payment o
Oklahoma opioid claims cost Teva $85M https://seekingalpha.com/news/3466934-oklahoma-opioid-claims-cost-teva-85m?source=feed_news_all May 26, 2019 - Teva Pharmaceutical (NYSE:TEVA) has agreed to an $85M settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the
Teva settles with Oklahoma for $85 million in opioid case http://www.startribune.com/teva-settles-with-oklahoma-for-85-million-in-opioid-case/510449062/ May 26, 2019 - One of the drugmakers named in Oklahoma's lawsuit over the opioid crisis has agreed to a settlement in which it will pay the state $85 million.
Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries, Endo ... http://www.gurufocus.com/news/883458/orbimed-advisors-llc-buys-neurocrine-biosciences-inc-teva-pharmaceutical-industries-endo-international-plc-sells-biogen-inc-celgene-corp-allergan-plc May 22, 2019 - Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries, Endo International PLC, Sells Biogen Inc, Celgene Corp, Allergan PLC, Stocks: NBIX,EW,MGTX,BMY,MYOK,APLS,TEVA,ENDP,PRTA,CDNA,CBA, release date:May 22, 2019

Pages: 123456789...87

<<<Page 4>